UPCC 43419: Prospective Study of Immune Biomarkers in Patients with Multiple Myeloma

Age
99 years or below
Gender
All
participants needed
30
Location
1

Brief description of study

The objective of this exploratory observational cohort study is to obtain blood samples - and in some cases, bone marrow aspirate samples - from patients with multiple myeloma for study in the laboratory.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: myeloma
  • Age: 99 years or below
  • Gender: All
Updated on 04 Aug 2024. Study ID: 834039
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research